These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia. Fibach E; Rachmilewitz EA Ann N Y Acad Sci; 2010 Aug; 1202():10-6. PubMed ID: 20712766 [TBL] [Abstract][Full Text] [Related]
23. Treatment of iron overload in thalassemia. Cianciulli P Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():208-13. PubMed ID: 19337180 [TBL] [Abstract][Full Text] [Related]
24. Reproductive health in patients with beta-thalassemia. Tolis GJ; Vlachopapadopoulou E; Karydis I Curr Opin Pediatr; 1996 Aug; 8(4):406-10. PubMed ID: 8954276 [TBL] [Abstract][Full Text] [Related]
27. Iron overload and toxicity: the hidden risk of multiple blood transfusions. Shander A; Cappellini MD; Goodnough LT Vox Sang; 2009 Oct; 97(3):185-97. PubMed ID: 19663936 [TBL] [Abstract][Full Text] [Related]
28. Pregnancy in patients treated for beta thalassemia major in two centers (Ali Asghar Children's Hospital and Thalassemia Clinic): outcome for mothers and newborn infants. Ansari S; Azarkeivan A; Tabaroki A Pediatr Hematol Oncol; 2006; 23(1):33-7. PubMed ID: 16326410 [TBL] [Abstract][Full Text] [Related]
30. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major. Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436 [TBL] [Abstract][Full Text] [Related]
31. [Pregnancy management in women with thalassemia]. Morelli M; Noia R; Zullo F; Corea D; Arduino B; Piccione F; Mastrantonio P Minerva Ginecol; 2000 Oct; 52(10):381-4. PubMed ID: 11236339 [TBL] [Abstract][Full Text] [Related]
32. Beta-thalassemia major and successful pregnancy. Kumar RM; Rizk DE; Khuranna A J Reprod Med; 1997 May; 42(5):294-8. PubMed ID: 9172120 [TBL] [Abstract][Full Text] [Related]
33. Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity. Lekawanvijit S; Chattipakorn N Can J Cardiol; 2009 Apr; 25(4):213-8. PubMed ID: 19340344 [TBL] [Abstract][Full Text] [Related]
34. Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Farmakis D; Giakoumis A; Polymeropoulos E; Aessopos A Med Sci Monit; 2003 Jan; 9(1):RA19-22. PubMed ID: 12552254 [TBL] [Abstract][Full Text] [Related]
35. IMPAIRED ENDOTHELIAL FUNCTION IN PEDIATRIC HEMOGLOBIN E/β-THALASSEMIA PATIENTS WITH IRON OVERLOAD. Aphinives C; Kukongviriyapan U; Jetsrisuparb A; Kukongviriyapan V; Somparn N Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1454-63. PubMed ID: 26466432 [TBL] [Abstract][Full Text] [Related]
36. Pregnancy and lactation in homozygous beta-thalassemia major. Surbek DV; Glanzmann R; Nars PW; Holzgreve W J Perinat Med; 1998; 26(3):240-3. PubMed ID: 9773387 [TBL] [Abstract][Full Text] [Related]
37. Impact of iron overload in myelodysplastic syndromes. Fenaux P; Rose C Blood Rev; 2009 Dec; 23 Suppl 1():S15-9. PubMed ID: 20116635 [TBL] [Abstract][Full Text] [Related]
38. Malignancies in β-thalassemia patients: first description of two cases of thyroid cancer and review of the literature. Poggi M; Sorrentino F; Pascucci C; Monti S; Lauri C; Bisogni V; Toscano V; Cianciulli P Hemoglobin; 2011; 35(4):439-46. PubMed ID: 21797713 [TBL] [Abstract][Full Text] [Related]